Navigating a Global Marketplace: Managing the Manufacturing, Sales and Distribution of Drugs and Medical Devices by Being Vigilant of the Latest Anti-Corruption Pitfalls

March 12, 2015 1:30pm

Maura K. Monaghan
Debevoise & Plimpton LLP

Katherine DeKam
Chief Compliance Officer – Director of Compliance
Acumed, LLC

Michael Russell Clarke
VP, Ethics & Compliance – Americas
Actavis, Inc.

Parth Chanda
Assistant General Counsel, Anti-Corruption Program
Pfizer Inc


Marco A. Gonzalez Jr.
Nicoll Davis & Spinella LLP

  • China: Lessons learned from recent anti-corruption enforcement actions
  • Overseas Training: Addressing FCPA and global anticorruption standards with your overseas sales force
    • Vetting criteria to determine who might be more compliant
    • Dealing with 3rd party intermediaries
    • Best practices for minimizing risks
  • Best practices for due diligence in vetting consultants, manufacturers, and vendors in high risk markets
  • Competing against local companies in cultures where gift giving is the norm
  • Establishing preventative internal controls measures to prevent and detect corruption